Effects of increased cross-sectional imaging on the diagnosis and prognosis of adrenocortical carcinoma: Analysis of the national cancer database

Journal of Urology

Volumn 186, Issue 3, 2011, Pages 805-810

  Kutikov, Alexander ^a   Mallin, Katherine ^b   Canter, Daniel ^a   Wong, Yu Ning ^a   Uzzo, Robert G ^a  

^a FOX CHASE CANCER CENTER   (United States)

^b AMERICAN COLLEGE OF SURGEONS   (United States)

Author keywords

adrenal glands; adrenocortical carcinoma; incidental findings; mass screening; neoplasm staging

Indexed keywords

ADRENAL CORTEX CARCINOMA; ADRENAL SCINTISCANNING; ADULT; AGED; ARTICLE; CANCER DIAGNOSIS; CANCER SIZE; CANCER SURGERY; DATA BASE; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROGNOSIS; SURVIVAL RATE;

ADOLESCENT; ADRENAL CORTEX NEOPLASMS; ADRENOCORTICAL CARCINOMA; ADULT; AGED; AGED, 80 AND OVER; DATABASES, FACTUAL; HUMANS; INCIDENTAL FINDINGS; MIDDLE AGED; PROGNOSIS; SURVIVAL RATE; YOUNG ADULT;

EID: 80051544790     PISSN: 00225347     EISSN: 15273792     Source Type: Journal    
DOI: 10.1016/j.juro.2011.04.072     Document Type: Article

References (27)

1. D.E. Schteingart, G.M. Doherty, and P.G. Gauger Management of patients with adrenal cancer: recommendations of an international consensus conference Endocr Relat Cancer 12 2005 667
2. A. Jemal, R. Siegel, and E. Ward Cancer statistics, 2009 CA Cancer J Clin 59 2009 225
3. B.L. Paton, Y.W. Novitsky, and M. Zerey Outcomes of adrenal cortical carcinoma in the United States Surgery 140 2006 914
4. L. Ng, and J.M. Libertino Adrenocortical carcinoma: diagnosis, evaluation and treatment J Urol 169 2003 5
5. P. Icard, P. Goudet, and C. Charpenay Adrenocortical carcinomas: surgical trends and results of a 253-patient series from the French Association of Endocrine Surgeons study group World J Surg 25 2001 891
6. M.L. Kendrick, R. Lloyd, and L. Erickson Adrenocortical carcinoma: surgical progress or status quo? Arch Surg 136 2001 543
7. L. Zini, U. Capitanio, and C. Jeldres External validation of a nomogram predicting mortality in patients with adrenocortical carcinoma BJU Int 104 2009 1661
8. E. Kebebew, E. Reiff, and Q.Y. Duh Extent of disease at presentation and outcome for adrenocortical carcinoma: have we made progress? World J Surg 30 2006 872
9. K.Y. Bilimoria, W.T. Shen, and D. Elaraj Adrenocortical carcinoma in the United States: treatment utilization and prognostic factors Cancer 113 2008 3130
10. W.F. Young Jr The incidentally discovered adrenal mass N Engl J Med 356 2007 601
11. J.M. Hollingsworth, D.C. Miller, and S. Daignault Rising incidence of small renal masses: a need to reassess treatment effect J Natl Cancer Inst 98 2006 1331
12. M.R. Cooperberg, K. Mallin, and J. Ritchey Decreasing size at diagnosis of stage 1 renal cell carcinoma: analysis from the National Cancer Data Base, 1993 to 2004 J Urol 179 2008 2131
13. K.Y. Bilimoria, A.K. Stewart, and D.P. Winchester The National Cancer Data Base: a powerful initiative to improve cancer care in the United States Ann Surg Oncol 15 2008 683
14. A. Fritz, C. Percy, and A. Jack International Classification of Diseases for Oncology 3rd ed. 2000 Geneva Health Organization Lyon
15. E. Shambaugh, J.L. Young, and C. Zippin Statistics and Epidemiology for Cancer Registrars, Self-instruction Manual for Cancer Registrars, Book 7: Surveillance Epidemiology and End Results Program 1995 National Institutes of Health Bethesda
16. M. Terzolo, A. Angeli, and M. Fassnacht Adjuvant mitotane treatment for adrenocortical carcinoma N Engl J Med 356 2007 2372
17. A.T. Phan Adrenal cortical carcinomareview of current knowledge and treatment practices Hematol Oncol Clin North Am 21 2007 489
18. M.M. Grumbach, B.M.K. Biller, and G.D. Braunstein Management of the clinically inapparent adrenal mass ("incidentaloma") Ann Intern Med 138 2003 424
19. A. Kutikov, P.L. Crispen, and R.G. Uzzo Pathophysiology, evaluation, and medical management of adrenal disorders A.J. Wein, L.R. Kavoussi, A.W. Partin, Campbell-Walsh Urology 10th ed. 2011 Elsevier Philadelphia
20. L. Barzon, N. Sonino, and F. Fallo Prevalence and natural history of adrenal incidentalomas Eur J Endocrinol 149 2003 273
21. M.K. Barry, J.A. van Heerden, and D.R. Farley Can adrenal incidentalomas be safely observed? World J Surg 22 1998 599
22. W.F. Young Jr Management approaches to adrenal incidentalomas A view from Rochester, Minnesota Endocrinol Metab Clin North Am 29 2000 159
23. G.B. Thompson, and W.F. Young Jr Adrenal incidentaloma Curr Opin Oncol 15 2003 84
24. F. Mantero, M. Terzolo, and G. Arnaldi A survey on adrenal incidentaloma in Italy J Clin Endocrinol Metab 85 2000 637
25. C.J. Kane, K. Mallin, and J. Ritchey Renal cell cancer stage migration: analysis of the National Cancer Data Base Cancer 113 2008 78
26. D.A. Kunkle, P.L. Crispen, and D.Y. Chen Enhancing renal masses with zero net growth during active surveillance J Urol 177 2007 849
27. A. Angeli, G. Osella, and A. Ali Adrenal incidentaloma: an overview of clinical and epidemiological data from the National Italian Study Group Horm Res 47 1997 279